Institut AllergoSan Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2020
NCT04593459
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Allergosan | Institut AllergoSan | Institute AllergoSan

Active Ingredients

Drugs in Phase 4 Trials (1)

metformin (glucophage) (1 trial)

Drugs in Other Trials (2)

bifidobacterium animalis (1 trial)

Lactobacillus acidophilus (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Polycystic Ovary Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3